Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Philips Respironics announces worldwide recall of trilogy ventilator

Respironics, a Philips Healthcare business, has initiated a worldwide recall of approximately 600 Philips Respironics trilogy ventilators to address a potentially defective component on the trilogy ventilator power management board.

On 11 February 2014, Philips Respironics has initiated a voluntary recall of trilogy ventilators that were shipped between 31 December 2013, and 30 January 2014. The recalled trilogy ventilator models include 100, 200 and 202

The potentially defective component on the trilogy ventilator power management board could affect the function of the device.

If the problem is not fixed, it is possible that the ventilator may fail to deliver mechanical breaths and that the alarm functionality may be reduced to indicate ventilatory failure. This would result in serious adverse health consequences or death.

Until now, no reports of death or serious injury related to this potential problem have been reported.

The trilogy ventilator has been designed to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation. The devices are intended to be used in home, institution/hospital, and portable applications such as wheelchairs and gurneys.

Philips Respironics, during production testing, found that the trilogy ventilators contain a potentially defective ferrite component on the power management board of the device.

The company has notified all US and international distributors, providers, and customers that may have devices subject to this recall, and has provided affected device serial numbers for identification.

Countries where affected devices have been shipped include the US, France, the UK, Hong Kong, India, Italy, Korea, Kuwait, Netherlands, and Singapore.